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Abstract
Chronic pain is common in people with Parkinson's disease and is often considered to be caused by the motor impairments
associated with the disease. Altered top‐down processing of pain characterises several chronic pain conditions and occurs when the
cortex modifies nociceptive processing in the brain and spinal cord. This contrasts with bottom‐up modulation of pain whereby
nociceptive processing is modified on its way up to the brain. Although several studies have demonstrated altered bottom‐up pain
processing in Parkinson's, the contribution of enhanced anticipation to pain and atypical top‐down processing of pain has not been
fully explored. During the anticipation to noxious stimuli, EEG source localisation reported an increased activation in the









mid [−1,500 –1,000]‐and late anticipation [−500 0], indicating enhanced cortical activity before noxious stimulation. The Parkinson's
disease group was also more sensitive to the laser and required a lower voltage level to induce pain. This study provides evidence
supporting the hypothesis that enhanced top‐down processing of pain may contribute to the development of chronic pain in
Parkinson's. Additional research to establish whether the altered anticipatory response is unique to noxious stimuli is required as no
control stimulus was used within the current study. With further research to confirm these findings, our results inform a scientific
rationale for novel treatment strategies of pain in Parkinson's disease, including mindfulness, cognitive therapies and other
approaches targeted at improving top‐down processing of pain.
Graphical Abstract
Parkinson's patients showed an increased activation in the midcingulate and supplementary motor area during the anticipation of
noxious stimuli. The augmented anticipation was independent of motor impairment, chronic pain severity, mood and
catastrophising behaviours. Therefore, demonstrating the high prevalence of chronic pain in Parkinson's may be caused by altered
central pain processing.
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fMRI functional magnetic resonance imaging
HADS hospital anxiety and depression scale
HC healthy control
LEP laser‐evoked potential
LORETA low resolution electromagnetic tomography
MCC midcingulate cortex
MDS‐UPDRS Movement Disorder Society Unified Parkinson's Disease Rating Scale
MoCA montreal cognitive assessment
PAG periaqueductal grey
PCS pain catastrophising scale
PD Parkinson's disease
PET positron emission topography
PFC prefrontal cortex
POI period of interest
PwPD people with Parkinson's disease
SASICA semiautomatic selection of independent components for artifact correction
SD standard deviation
SI/SII somatosensory cortex
SMA supplementary motor area
SPM statistical parametric mapping
TWOI time window of interest
VAS visual analogue scale
1. INTRODUCTION
1.1. Pain in Parkinson's disease
Chronic pain is a highly prominent symptom in people with Parkinson's disease (PwPD), yet there is a limited understanding of whether
the pain is primarily a consequence of motor impairment, including muscle rigidity, or whether Parkinson's disease (PD) causes a
centrally produced heightened sensitivity to pain. Whilst the percentage of the general population living with chronic pain is
approximately 20% (Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006; van Hecke, Torrance, & Smith, 2013), there is a significantly
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higher prevalence within the PD population of approximately two‐thirds (Nègre‐Pagès, Regragui, Bouhassira, Grandjean, & Rascol, 2008;
Ozturk, Gundogdu, Kocer, Comoglu, & Cakci, 2016; Silverdale et al., 2018; Skogar & Lokk, 2016). There is evidence that PwPD have lower
threshold and tolerance of pain compared to age‐matched healthy cohorts (Brefel‐Courbon et  al., 2005; Chaudhuri & Schapira, 2009;
Djaldetti et al., 2004; Schestatsky et al., 2007), and EEG and functional imaging studies have demonstrated an altered central response
to pain in PD (Brefel‐Courbon et al., 2005; Schestatsky et al., 2007; Tinazzi et al., 2009). These abnormalities provide strong evidence that
altered central pain processing contributes to the development of pain in PD (Silverdale et  al., 2018). Therefore, an increased
understanding of the pathophysiological mechanisms causing the chronic pain is imperative to make an informed improvement in the
treatment of pain in Parkinson's.
1.2. Top‐down alteration in pain processing
Research into chronic pain has largely focused on bottom‐up mechanisms amplifying the nociceptive information on its way from the
peripheries to the brain (Reicherts et  al., 2017; Watson et  al., 2009). Bottom‐up processing refers to the transmission and encoding of
sensory information from noxious stimuli, which is not affected by subjective modulation of pain perception. However, there is a
developing field in the role of top‐down modulation of pain, whereby the cortical activity modulates the nociceptive information.
Previous research within our group has used EEG source localisation to investigate the anticipatory processing of painful stimuli. Our
previous research has shown that the anticipation of pain leads to changes in the activity of the same brain regions that subsequently
respond to nociception (Brown, El‐Deredy, & Jones, 2014; Brown & Jones, 2008; Brown, Seymour, Boyle, El‐Deredy, & Jones, 2008; Clark,
Brown, Jones, & El‐Deredy, 2008). Examples of regions which have been seen to activate during anticipation include the cingulate cortex,
insula, primary and secondary somatosensory cortex (SI/SII), prefrontal cortex (PFC) and the periaqueductal grey (PAG) (Babiloni et  al.,
2004; Koyama, McHaffie, Laurienti, & Coghill, 2005). The degree of anticipation has been shown to be correlated with subsequent pain
perception and the EEG laser‐evoked potential (LEP) (Brown, Seymour, Boyle, et al., 2008). Hence, we have previously demonstrated that
the cortex can modulate the perception of pain of the incoming pain information via top‐down modulation. Within chronic pain
conditions, such as fibromyalgia and osteoarthritis, heightened anticipation within the insula cortex is correlated with the extent and
severity of chronic pain symptoms (Brown et al., 2014).
Unlike fMRI and PET, the higher temporal resolution of EEG allows for a more accurate recording of the anticipatory processes. Prior to a
noxious stimulus, during anticipation, there is cortical activity from a network of regions including the cingulate cortex, basal ganglia
and thalamic structures (Brunia & van Boxtel, 2001; Vogt, Finch, & Olson, 1992). In this study, we used EEG with source localisation
analysis because of the temporal advantage over neuroimaging techniques reliant on slow haemodynamic responses. The accuracy and
reliability of EEG source localisation has been verified by research which shows high similarity to other neuroimaging techniques such
as PET (Lantz, Grave de Peralta, Spinelli, Seeck, & Michel, 2003; Michel et al., 2004), fMRI (Mulert et al., 2004; Vitacco, Brandeis, Pascual‐
Marqui, & Martin, 2002) and intracerebral recordings (Seeck et  al., 1998; Trébuchon‐Da Fonseca, Giraud, Badier, Chauvel, & Liégeois‐
Chauvel, 2005). EEG source localisation has reliably reported activations within the regions associated with pain perception during
anticipation (Brown & Jones, 2012; Brown, Seymour, El‐Deredy, et  al., 2008; Brown, Seymour, Boyle, et  al., 2008). For instance, impaired
processing within the parietal and frontal regions during anticipation has been reported using source localisation in patients with the
chronic pain associated with fibromyalgia and osteoarthritis (Brown et al., 2014).
1.3. Aim of study
Here, we investigated anticipatory processing in PwPD in the ‘off ’ medication state in comparison to age‐matched healthy volunteers. We
used a CO  laser to induce acute noxious stimuli and monitored brain activity throughout via EEG. We hypothesised that the anticipatory
phase would be abnormal in the PD group and would provide evidence that top‐down mechanisms are key to explaining the
mechanisms of chronic pain in PD.
2. METHODS
The study was approved by the local ethics committee, and all participants gave informed consent according to the Declaration of
Helsinki to participate in the study. The study was registered with the National Institute of Health Research (NIHR) Central Portfolio
Management System (CPMS) (CPMS ID: 19963).
2.1. Participants
Twenty‐four participants with Parkinson's were recruited (sixteen males). PD patients were recruited via correspondence with their
neurologist (MS or CK). Participants were screened to ensure safe withdrawal of medication for the study, and to exclude cases of severe
tremors which might interfere with EEG recording. Clinically significant peripheral neuropathy was excluded by clinical examination and
neuropathy scale. Symptom duration ranged from 1  month to 16  years, with a mean duration of 5.13  years. One PD participant was
unable to complete the study due to severe symptoms after medication withdrawal. Twenty‐three participants with PD were included for
the analysis of behavioural measures. Twenty PD participants were included for EEG analysis due to two data sets being removed
because of noisy data and one for a low MoCA (Montreal Cognitive Assessment) score (12/30).
Twenty‐five age‐matched healthy controls (HCs) were recruited (fourteen males). One HC participant was unable to complete the study
due to the laser failing to induce a sufficient pain level, and one HC data set was removed due to noisy data. Twenty‐four HCs were
included in the behavioural measures, and 23 HC participants were included for EEG data analysis. The participants with PD [age range:
min 46, max 83, median: 66, mean  ±  SD: 63.3  ±  8.27  years] were age‐matched to the HCs [age range: min 45, max 82, median: 63,
mean ± SD: 65.5 ± 8.59 years].
2.1.1. Medication
The PD group omitted their evening medication and were studied in the practically defined OFF state (after 12 hr of withdrawal of anti‐
Parkinsonian medication). All analgesic medication was withdrawn 12  hr prior to the study visit. The motor section of the Movement
Disorder Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) was completed to report the current severity of their
parkinsonian disability off their medication.
2.1.2. Assessments
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The participants were assessed for PD motor severity, pain, mood and cognitive state. PD motor severity: The motor section (III) of the
MDS‐UPDRS was completed to evaluate the motor disability due to PD (Goetz et  al., 2008). The assessment in the PD group was
completed off their medication. Pain: All participants rated their current pain state via a visual analogue scale (VAS) prior to starting the
laser protocol. The PD participants with chronic pain reported their minimum and maximum degree of pain over the last 6 months via a
visual analogue scale (VAS). All participants completed the pain catastrophising scale (PCS) (Sullivan et  al., 1995) to report their
psychological coping ability when experiencing pain. Mood: All participants completed the Hospital Anxiety and Depression Scale (HADS)
(Zigmond & Snaith, 1983) to dissociate results from anxiety or depression. Cognitive state: The Montreal Cognitive Assessment (MoCA)
(Nasreddine et al., 2005) test was carried out to assess the participants’ cognitive ability. Participants with low scores (<25) were removed





A CO₂ laser [50W Synrad 48‐5J‐series (J‐48‐5(S)W) Wavelength: 10,600  nm] was used to deliver acute pain to the dorsal surface of the
right forearm. The CO₂ laser delivered a beam with a diameter of 15  mm and 150  ms duration. The voltage (V) of the laser is linearly
related to the laser voltage delivered to the forearm. For each test, the stimuli were delivered in an area measuring 4 × 5 cm and were
delivered in a pre‐determined randomised path (Brown, Seymour, Boyle, et al., 2008). This was to avoid habituation, sensitisation or skin
damage.
2.2.2. Psychophysics
Before starting the experimental protocol, psychophysics was used to calibrate the laser to the individual's pain sensitivity. An
ascending method of limits procedure was used, starting from 0.6  V with 0.06 increments each time. The participant used an eleven‐
point VAS (0–10) to rate the intensity of the pain perceived for each stimuli and the following description was provided; 0 = no sensation,
4  =  pain threshold, 7  =  moderately painful, 10  =  unbearably painful. The rating scale was introduced to the participant via these
standardised descriptives to ensure that no explanation altered their interpretation of the scale. The procedure was repeated three
times to allow participants to get used to the laser and was used to calculate the average voltage to induce level 4 (low) and level 7
(moderate) pain. These two levels provided ‘low’ and ‘high’ stimuli intensity for the main laser experiment protocol.
2.2.3. Main experiment
The participants received 120 laser stimuli at the two intensities (low and high) separated into four conditions; low (level 4), high (level
7), unknown low (level 4) and unknown high (level 7). To investigate the anticipation of a painful stimulus, a 3‐s countdown was delivered
by three auditory cues at 1  s intervals (see Figure  1). The first auditory cue was presented concurrently with an anticipatory cue to
indicate the forthcoming laser stimuli and to maintain attention. The participant was either shown ‘Low’, ‘High’ or ‘Unknown’. The
presentation of the word ‘Unknown’ indicated that the laser stimulus has an equal chance of being low or high. This was to investigate
Fig. 1
the importance of certainty in the anticipation of the laser stimuli. The image was also used as a visual fixation cue to discourage eye
movements. After the laser stimuli, the 0–10 numerical rating scale was shown on the screen and the participant rated the intensity of
the pain. The order of the stimuli was randomised and separated into three blocks with short breaks in‐between.
A schematic diagram of a single trial of the experimental paradigm. A computer monitor showed the participant a visual cue
of low, high or unknown from −3 s to +2 s. A 3‐s countdown of beeps at −3, −2 and −1 allowed accurate anticipation of the
laser stimuli at time 0s (red bar). The presentation of the visual cue at −3 s was concurrent with the first auditory cue. The
visual cue was consistent throughout the anticipation and laser stimulus. At +2 s, an eleven‐point visual analogue scale (VAS)
was presented for the participant to rate the laser stimulus. For each condition (low, high, unknown low and unknown high),
there were thirty trials. The trials were presented in a randomised order and divided into three blocks of forty trials
2.2.4. EEG recording
A BrainVision MR EEG cap was used to record from 63 scalp electrodes using a BrainVision cap system [Standard BrainCap‐MR with
Multitrodes]. The arrangement of the electrodes was modelled on the extended 10–20 system. Recording parameters were set at filter
(DC to 70 Hz), sampling rate (1,000 Hz) and gain (500). To reduce electrical interference, a 50‐Hz notch filter was applied. Prior to starting
the laser protocol, resting states were recorded with eyes open and closed for 2 min in all participants. This ensured that the experience
prior to the experiment was identical. The resting state data will be analysed and reported separately. The three experimental blocks
were recorded separately to allow for better artefact rejection of the EEG data.
2.3. Analysis methods
2.3.1. Statistical analysis of behavioural data
Statistical analyses of the behavioural measures were carried out using IBM SPSS Statistics 22 software. The questionnaires were all
investigated for significant group differences. Prior to using statistical tests, the data were assessed for normality using a combination
of Q‐Q plots, histograms, and the values of skew and kurtosis. Normally distributed data were analysed using independent t tests and
ANOVA tests, whilst data reported to be not normally distributed (namely the PCS, HADS, laser voltage to induce level 7 pain), a non‐
parametric test was utilised. Specific statistical tests for each analysis step are reported in the results section.
2.3.2. EEG analysis method AQ5
EEG pre‐processing was carried out using EEGLAB toolbox (Delorme & Makeig, 2004) in MATLAB version R2015a (the MathWorks Inc),
whilst statistical analysis was carried out using SPM12 toolbox (Wellcome Department of Imaging Neuroscience, Institute of Neurology,
UCL, London, United Kingdom) running in MATLAB. The EEG data were pre‐processed for scalp and source localisation analysis. The
main motivation of the analysis was to establish the anatomical origin of the brain activity using (low‐resolution electromagnetic
tomography) LORETA source localisation.
EEGLAB pre‐processing
Pre‐processing consisted of removal and interpolation of bad channels, down‐sample to 500 Hz, low‐pass filter of 20 Hz and re‐reference
to the common average. The four conditions were separated and −3,500  ms to 2,000  ms epochs extracted and linear detrend applied.
Independent component analysis (ICA) was carried out on all data sets using the SemiAutomatic Selection of Independent Components
for Artifact correction (SASICA) toolbox to select components to remove via pre‐determined thresholds. The thresholds were set to
autocorrelation (threshold = 0.35 r, lag = 20 ms), focal (threshold = 3.5 z), focal trial (threshold 5.5 z), signal to noise (period of interest
(POI)  =  [0 Inf], baseline (BL) [−Inf 0], threshold ratio  =  0.5), and adjust selection enabled. The thresholds were sufficient to remove
artefacts from the majority of the data sets; however, a number of data sets required further manual removal of eye‐blink components
where not picked up by SASICA.
SPM EEG analysis
The pre‐processed data sets were converted to statistical parametric mapping (SPM) compatible files. Statistical analysis was carried out
to investigate the anticipation‐evoked potentials and the post‐stimulus LEPs using scalp‐level and source localisation analysis
techniques available in the SPM toolbox.
SPM scripts for batch processing were used to analyse the EEG data at the scalp‐level and source localisation. Two baselining methods
were applied to the data analysis for the anticipation phase and were applied for scalp‐level and source localisation analysis. Primary
analysis applied distinct baselines (BLs) of 500 ms, occurring prior to each of the three auditory cues, respectively, to analyse each of the
three anticipation phases. The BLs and time window of interest (TWOI) were as follows: early [BL: −3,500 ms −3,000 ms: TWOI: −2,500 ms
−2,000  ms], mid [BL: −2,500  ms −2,000  ms: TWOI: −1,500 −1,000  ms]‐and late [BL: −1,500 −1,000  ms: TWOI: −500 0  ms] anticipation
phases. The aim of baselining uniquely for each anticipation window was to reduce variability in the data as the anticipation phase
progressed, such that the analysis of each phase of anticipation was unique to that phase and not subject to variability arising from
neural activity occurring in the previous phase. The secondary analysis method applied a single baseline of 500  ms prior to the first
auditory cue [BL: −3,500  ms −3,000  ms] that was common to every TWOI anticipation phase (early, mid and late). This second analysis
was conducted to enable comparison to previous studies (Brown, Seymour, Boyle, et  al., 2008; Brown et  al., 2014) that used the same
baselining method, and to explore to what extent the results from the primary analysis were dependent on the baselining method used.
All statistical analyses for the anticipation phase were adjusted for multiple comparisons.
All analyses for the post‐stimulus phase TWOI [200 ms 600 ms], centred on the LEP, were baseline corrected to −500 ms prior to the laser
stimulus [BL: −500 ms 0 ms].
We also calculated the SD (standard deviation) of the EEG potential over trials for every time sample across the whole epoch [−3500
1,500  ms] and compared the results between the two groups to evaluate for possible differences in variability of the data over trials.
This was to test whether any group differences found in ERP amplitudes and sources from the main analyses might have resulted from
differences in data variability; such variability can arise from noise in the EEG signal (including motion and other artefact) rather than
from neural signals. Such noise was expected to be greater in the PD group and therefore required assessing in order to interpret the
results.
Source localisation analysis parameters
SPM12 EEG and MATLAB scripts were used to estimate the sources of the anticipation‐ and laser‐evoked potentials using LORETA. The
forward model was created using an 8196 vertex template cortical mesh coregistered to the electrode positions of the standard 10–20
EEG system. A three‐shell boundary element model (BEM) EEG head model available in SPM12 was used to compute the forward model.
The images were smoothed with a 12 mm full width at half maximum (FWHM).
2.3.3. EEG analysis statistical analysis
For the analysis of the anticipatory TWOIs, a three‐way repeated measures ANOVA was applied, with one between‐subject factor of
group (HC vs. PD) and two within‐subject factors of certainty [known (low/high) v unknown] and expectation [low vs. high (known)]. For
the analysis of the post‐stimuli TWOI, a three‐way repeated measures ANOVA was applied, with one between‐subject factor of group (HC
vs. PD) and two within‐subject factors of certainty [known (low/high) vs. unknown] and intensity [low v high (known and unknown)].
Source localisation results were reported as follows. To control for multiple comparisons, a cluster‐forming threshold of p  <  .001 was
used and resulting clusters were considered significant at FWE (p < .05). In addition, the clusters which did not reach significance after
FWE, yet were significant at the uncorrected threshold, were also reported if the location of the clusters were within regions associated
with anticipation. The inclusion of such source clusters is highlighted when reported. Significant clusters were also restricted to > 100
voxels in size and regions labelled using the anatomical automatic labelling (AAL2) toolbox in SPM. We extracted the eigenvariate data
from significant source estimates to investigate possible correlations with behavioural measures including MDS‐UPDRS (PD group only),






Group comparisons were carried out using a Mann–Whitney U test of questionnaire scores. Our study did not show evidence of a
significant difference between PD and HC groups reported in the PCS (U  =  177.50, p  =  0.198) or HADS (U  =  212, p  =  0.660). The
distributions of the questionnaire scores are shown in Figure 2. The OFF MDS‐UPDRS‐III motor score recorded in the PD group ranged
from 15 to 78, with a mean of 38.3 ± 16.56. For reference, a high MDS‐UPDRS‐III score indicates more severe movement impairments.
The individual scores for (a) Pain Catastrophizing Scale (PCS) and (b) Hospital Anxiety and Depression Scale (HADS). There
was no evidence of a difference in either questionnaire between the two groups
3.1.2. Laser behavioural results
The psychophysics ramping procedure was used to calculate the participants’ individual voltage level required to induce a high pain
score. An independent sample t test with a Welch's degrees of freedom correction was used to determine if there were differences
between the HC and PD groups in the voltage required to induce a high pain score. There was a statistically significant difference in
voltage required to induce a high pain between HC and PD (Figure 3), with PD requiring a lower voltage level (1.99 ± 0.44 V) compared to
HC (2.20  ±  0.25  V), (95% CI, 0.21 [0.003–0.432], t(34.75)  =  2.060, df  =  34.75, p  =  0.047). To assess whether the severity of the PD
participants’ movement symptoms was correlated with individual pain tolerance, a correlation between the pain tolerance (measured as
the voltage of the laser required to induce high pain) and the severity of movement impairment and muscle rigidity in the PD
Fig. 3
participants (MDS‐UPDRS(iii)) was completed using Spearman's correlation and reported no significant correlation, r (43)  =  −0.177,
p = 0.257 (see Figure 4).
The voltage of the laser required to induce high (level 7) pain. The PD group required a lower voltage level compared to the
HC group to induce the equivalent pain. Data are presented as a dot plot to display the individual results and show the
spread of the data within each group. Laser voltage was delivered from 0.8 V to a maximum of 2.5 V in increments of 0.06 V.
*p < .05. HC, healthy control; PD, Parkinson's disease
s
Fig. 4
The PD group was assessed for a relationship between the severity of their movement impairment and their tolerance to the
laser (measured as the voltage of the laser required to induce a level 7 pain). A Spearman's rank correlation did not show
evidence of a relationship between the MDS‐UPDRS(iii) and the laser voltage in the PD group
The mean and standard error (SE) of the pain rating scores for all conditions were calculated: low (PD: 2.54 ± 0.23, HC: 2.0 ± 0.18), high
(PD: 4.94 ± 0.30, HC: 4.7 ± 0.26), unknown low (PD: 3.06 ± 0.25, HC: 2.4 ± 0.22) and unknown high (PD 4.53 ± 0.33, HC: 4.1 ± 0.26). The pain
rating scores for the laser stimuli during the main experiment were investigated using a three‐way mixed ANOVA with a between‐
subject factor of group and within‐subject factors of certainty (known v unknown) and intensity (low v high). The data met homogeneity
threshold (p  >  0.05) calculated by the Levene's test of equality of variances. There was no effect of group F(1, 43)  =  2.347, p  =  .133,
η   =  0.52. There was an effect of intensity F(1, 43)  =  290.992, p  =  .000, η   =  0.871, yet no effect of certainty F(1, 43)  =  0.006, p  =  .937,
η  = 0.000. However, there was a significant two‐way interaction between certainty and intensity F(1, 43) = 59.188, p = 0.000, η  = 0.579,
such that the pain ratings of unknown low were higher (+0.52  V) compared to known low, whilst ratings of unknown high were lower
(−0.46  V) compared to known high (see Figure  5). This result acts as a manipulation check that demonstrates that the experiment was
successful in inducing expectations (via anticipation cues) that modulated pain in the expected direction as seen in previous research
(Brown, Seymour, El‐Deredy, et al., 2008). The study did not find evidence of a significant difference in the effect of intensity or certainty




The pain rating for each laser condition is displayed for the HC and PD groups. There was a significant interaction between
certainty and intensity such that unknown low was rated higher than known low, whilst unknown high was rated lower than
known high. This result was shown in both the HC and PD groups. UnLow, ‘Unknown’ Low; UnHigh, ‘Unknown’ High; HC,
healthy controls; PD, Parkinson's disease; NRS, Number Rating Scale
3.2. EEG results
3.2.1. Scalp‐level Whole‐head analysis
SPM whole‐head statistical analysis of the early [−2,500 −2,000  ms], mid [−1,500 −1,000  ms]‐and late [−500 0  ms] anticipatory phases
reported no evidence of a significant difference of group, certainty or expectation. This was true for both baseline methods (see
Methods section). Similarly, the post‐stimulus TWOIs [200 600 ms] reported no significant group or certainty differences. The intensity
factor in the post‐stimulus TWOI reported increased activity in high pain condition compared to low pain (SPM results reported in
Table S1).
The anticipatory response over time was calculated for each participant and displayed as topography plots in Figure  6 and highlights
the variability in sensor‐level response within each group. The average response for mid‐ and late anticipation for the HC and PD groups
is shown in Figure 7. In addition, the difference between HC and PD group was also determined by subtracting the HC amplitudes from
the PD data and shown in Figure 7. Despite the SPM scalp‐level analysis not reporting a significant difference, an anticipation response
is seen in the central scalp region which is more prominent in PD than HC. Because scalp responses are a summation of deeper brain
events from different sources, the scalp‐level analysis was hence followed up by source localisation analysis.
Fig. 6
Fig. 7
The sensor‐level neural response was averaged across time for each channel and plotted as topoplots. An individual
topography is shown for the average response for mid‐ [−1500 −1000 ms] and late [−500 0 ms] anticipation time windows for
HC and PD. Mid‐anticipation is baseline corrected to [−2,500 −2,000 ms] and late anticipation to [−1,500 −1,000 ms]. The scale
is set at –1 to 1 μV for all plots

Fig. 8
Topography plots showing the average response for the mid‐ and late anticipation time windows for HC and PD. Mid‐
anticipation is baseline corrected to [−2,500 −2,000 ms] and late anticipation to [−1,500 −1,000 ms]. The difference between
the PD and the HC group was calculated via subtracting the HC data from the PD data. The same scale has been used for all
topography plots. In the group difference plot, the red (1) highlights a more positive response in the PD participants, whilst
blue (-1) indicates a more negative amplitude in PD
AQ6
AQ7
3.2.2. Source EEG analysis
Group differences
Source localisation analysis using the distinct baselines prior to the auditory cues revealed that the PD group showed a higher degree of
activity compared to the HC group during mid‐ and late anticipation phases (see Figure 8). The F‐ and T‐contrasts for group difference in
each anticipation time window are outlined in Table  1. The clusters which are denoted with ‘◊’ in Table  1 were used for correlation
analysis with subsequent behavioural parameters. Source clusters were also reported at the uncorrected level if they were within
regions previously associated with anticipation including the hippocampus (Reicherts et al., 2017), the postcentral gyrus (Yang, Jackson,
& Huang, 2016) and the cingulate cortex (Shackman et  al., 2011). Hence, there is evidence for a potential difference within the early
anticipation between the two groups. The difference in neural activity between the two groups is shown in Figure 9 which displays the
eigenvariate values for all clusters outlined in Table 1 for HC and PD groups.
Source estimates for significant F‐contrasts using MRIcroN software. Data are presented non‐thresholded and presented as
F‐statistic, from low to high. The red areas highlight the regions where the PD group showed evidence of a statistically
significant increased activation compared to the HC group during anticipation to the noxious stimuli. Panel (a) shows the
increased activation in the PD group during the mid‐anticipation phase [−1,500 −1,000  ms] and is baselined to [−2,500
−2,000 ms]. The PD group showed increased activation in the bilateral midcingulate cortex (MCC) and supplementary motor
area (SMA). Panel (b) shows the increased activity within the PD group during the late anticipation phase [−500 0 ms] and is
baselined to [−1,500 −1,000 ms]. The regions of increased activity included the bilateral MCC and precuneus
Table 1 Group effect on sources of early, mid‐ and late anticipation‐evoked responses
    Group difference   Brain region Cluster
Ref
Cluster level Peak level MNI coordinates





413 13.79 3.45 16 −22 −16 R Hippocampus (47.5%) A
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A threshold of clusters > 100 voxels was set and results were restricted to FWE correction and the p value adjusted for multiple
comparisons (p < .025). Results labelled with ‘◊’ met these criteria and are used for Figure 8 and correlation analysis (Figures 11 and
12). In addition, clusters are also reported for results which did not show significance after FWE, yet showed significance at the
uncorrected (Uncorr) threshold and were within regions which have previously been associated with anticipation. These clusters are
signified with †, and both FWE and uncorrected p values are shown. Each cluster has been assigned a letter for reference in other
figures. Figure 9 displays the eigenvariate values extracted for each cluster (A–L) at the F‐ and T‐contrasts to show the distribution
within the HC and PD groups. The anatomical automatic labelling (AAL2) atlas was used to report the regions within the significant
cluster for the group effect. The region with the highest percentage overlap is shown, unless an equivalent share of percentage
overlap was seen. A label of ‘Unknown’ was not reported. The full report of all of the percentage overlaps can be seen in the Table S3.
Following source localisation, the eigenvariate values were extracted from all clusters which showed group differences
between HC and PD outlined in Table 1. The eigenvariate values are plotted for the HC and PD groups and reported with
group mean and standard deviation error bars. Significance is highlighted for each comparison such that *p  <  0.05,
**p < 0.01, ***p < 0.001. The significant uncorrected p value is reported for results which did not reach significance at FWE
During early anticipation, there was possible evidence that the presentation of the ‘Unknown’ visual cue induced a higher degree of
activity in comparison with the known conditions of ‘Low’ and ‘High’. The F‐contrast cluster did not reach FWE significance (p  =  .053,
F = 19.87, k   =  520); however, the uncorrected p value of 0.019 and visual inspection of the eigenvariate value distribution within each
group (Figure 10) warranted follow‐up t tests. The T‐contrast (unknown>known: p = 0.013, T = 4.32, k  = 967), with peak voxel at x:48 y:16




superior temporal pole (37.5%), right mid‐temporal pole (18.3%), right superior temporal (14.6%) and the right insula (3.7%). Contrasts
for expectation (low v high) during anticipation, and certainty (known v unknown) within the post‐stimulus TWOI, did not show evidence
of significant differences in source estimates. During the post‐stimuli TWOI, there was a significant difference in the intensity, such that
a greater response was seen in the high intensity condition compared to low (see Table S2).
Source localisation analysis indicated that the presentation of an unknown cue induced a higher level of neural activity
during early anticipation in comparison with the known cues of ‘Low’ and ‘High’. The cluster was located within the right
superior temporal pole, mid‐temporal pole, superior temporal region and insula. The effect of certainty on neural activity did
not reach significance at FWE (p  =  0.053). Nevertheless, the uncorrected p value (0.019) in combination with the higher
eigenvariate values for the unknown condition shown in the dot plot indicates that a difference is likely
Source correlations with behavioural measures
The eigenvariate data from the source estimates which reached significance after FWE correction (denoted with ‘◊’ in Table  1) for the
mid‐ and late anticipation group effects were extracted for correlation analysis. Spearman rank correlation of mid‐anticipation clusters
(Table 1: clusters C and D) and the late anticipation cluster (Table 1: cluster K) were investigated for correlation with MDS‐UPDRS motor
score (PD only), HADS, PCS, maximum chronic VAS score (PD only), the voltage of the laser and pain rating. The distributions of the data
are shown in Figures  11 and 12. The p value was adjusted to account for multiple comparison, and no significant correlations were
highlighted.
Fig. 11
Scatterplots of the relationships between the anticipatory neural activity and the behavioural results. Following source
localisation, the eigenvariate values were extracted from clusters which showed a significant group difference at FWE
correction (see Table 1). Within mid‐anticipation, two clusters located within the MCC and SMA (C and D) were investigated
for correlations between the behavioural factors; MDS‐UPDRS(iii) (PD only), max chronic pain (PD only), HADS, PCS, laser
voltage for high pain and average pain rating. Spearman rank correlation analysis did not report any significant correlations
Fig. 12
Scatterplots of the relationships between the anticipatory neural activity and the behavioural results. Following source
localisation, the eigenvariate values were extracted from clusters which showed a significant group difference at FWE
correction (see Table 1). Within late anticipation, one cluster within the MCC and precuneus (cluster K), was investigated for
correlations between the behavioural factors; MDS‐UPDRS(iii) (PD only), max chronic pain (PD only), HADS, PCS, laser voltage
for high pain and average pain rating. Spearman rank correlation analysis did not report any significant correlations
3.2.3. Standard deviation analysis
The analysis of the SD‐over‐trials across the whole epoch at sensor‐level EEG revealed no significant differences between the HC and PD
groups, nor within‐subject contrasts, certainty or expectation.
4. DISCUSSION
In the present study, we used EEG source localisation techniques to investigate the pain processing in PwPD in the practically defined
OFF state (after 12 hr of withdrawal of anti‐Parkinsonian medication). There were three main findings. Firstly, the PD group were more
sensitive to the laser and required a lower voltage level to evoke painful stimuli. Secondly, EEG source localisation showed that the PD
group had a heightened anticipatory activity during the anticipation phase prior to acute heat pain. And finally, the heightened
anticipatory response was independent of PD motor severity (MDS‐UPDRS), mood (HADS), pain coping mechanisms (PCS) and severity of
chronic pain (max chronic VAS score). This present study provides evidence to support the hypothesis that there is an augmented top‐
down processing during the anticipation of pain in PwPD which may help us to understand the high prevalence of pain in PwPD.
4.1. Pain tolerance
The pain tolerance of the participants was assessed via the voltage required of the laser required to induce a level 7 pain. We observed
that overall the PD group required a lower voltage and were hence more sensitive to the laser than the HC group. This difference was
potentially driven by a subgroup of six PD individuals whom required a voltage that was lower than the lowest HC value. To establish
whether their sensitivity to the laser corresponded with similarities in neural responses, we looked at their scalp‐level topography and
extracted eigenvariate values from source estimates for the anticipatory time windows. We did not identify any connecting
characteristics within the PD subgroup that would define them as a distinct subgroup of PD.
4.2. Altered top‐down control
The amplified anticipatory response seen in the PD group is evidence of altered top‐down modulation prior to the nociceptive
information reaching the brain. This opens the possibility that the heightened pain sensitivity in PD is not solely due to impaired
peripheral, bottom‐up, factors, but may also be due to the modulation within the brain.
The significance of altered top‐down processing is well established in the pain field: different attentional states can directly and
substantially alter pain intensity and unpleasantness (Miron, Duncan, & Bushnell, 1989); anxious anticipation of aversive stimuli
activates regions associated with pain perception, resulting in altered perception of the stimuli (Reicherts et al., 2017). Furthermore, the
degree of anticipation of a noxious stimulus has been shown to directly correlate with the perceived stimuli intensity (Fairhurst, Wiech,
Dunckley, & Tracey, 2007; Pfingsten et al., 2001), and abnormal anticipation of a painful stimulus has been shown in a number of chronic
pain conditions such as fibromyalgia (Brown et al., 2014; Burgmer et al., 2011; González‐Roldán et al., 2016).
Here, we have shown increased cortical activation in the PD group during the anticipation of painful stimuli, including the midcingulate
cortex (MCC), supplementary motor area (SMA) and precuneus. Importantly, the group effects seen during anticipation were
independent of the MDS‐UPDRS, PCS and HADS emphasising that it is likely that the underlying PD pathological process is causing the
greater anticipatory activity rather than the consequence of motor impairment, coping mechanisms and mood state. The fact that the
abnormal processing is independent of the MDS‐UPDRS supports the hypothesis reported in Silverdale et  al., 2018 that the high
prevalence of chronic pain in PD is independent of the severity of the motor impairments and could be due to top‐down modulation of
the nociceptive information.
Our results are consistent with a single previous fMRI study, using a very different protocol which demonstrated that PwPD showed a
significantly reduced activation within the inhibitory descending pain pathway during the anticipation of pain and an increased
activation within the MCC during pain perception (Forkmann et  al., 2017). In combination with the results presented in this current
study, and evidence which has shown similar altered anticipatory processing in chronic pain conditions (e.g. FM), we reason that PwPD
display maladaptive top‐down modulation during pain processing which may help to explain the high prevalence of pain within the PD
community. However, a definite conclusion of a causal link between altered anticipatory processing in PD and chronic pain prevalence
cannot be confirmed without further investigations.
4.3. Regions activated during the anticipatory response
The location of the amplified anticipatory signal within the PD group during mid‐ and late anticipation was mainly, but not limited to,
the SMA and the MCC. The SMA and MCC have a role in the selection and planning of movements (Morecraft & Van Hoesen, 1998;
Rushworth, Walton, Kennerley, & Bannerman, 2004; Russo, Backus, Ye, & Crutcher, 2002), and are indicated to be involved in the
prediction of aversive events and the movement response required (Morrison, Peelen, & Downing, 2007). The SMA and the MCC have
shown overlapping functional connectivity during pain processing and motor control (Misra & Coombes, 2015), and enhanced activation
within the SMA has been associated with patients with phantom limb pain (Dettmers et al., 2001).
The MCC is a region involved in cognitive processing and is associated with the fear response, pain processing and specific motor
outcomes to painful stimuli (Shackman et  al., 2011; Vogt, Berger, & Derbyshire, 2003). Abnormal connectivity within the MCC is
associated with patients with migraines (Hubbard et al., 2014), and a heightened response within the MCC has been reported in PwPD
during pain perception (Forkmann et  al., 2017). In addition, in an extensive rodent study, the MCC showed to be central to the
development of pain hypersensitivity in the absence of peripheral noxious stimuli (Tan et  al., 2017). The study also demonstrated that
silencing the MCC via optogenetic techniques partially reversed inflammatory hypersensitivity, thus highlighting the role of MCC in the
development of chronic pain conditions (Tan et al., 2017).
Additionally, the MCC is also associated with reward processing (Hayden, Nair, McCoy, & Platt, 2008; Pearson, Hayden, Raghavachari, &
Platt, 2009; Shackman et  al., 2011), a process highly dependent on dopaminergic signalling and hence may be important due to the
depletion of dopamine seen in PD. Abnormal reward processing is a possible predictor of the development of increased pain sensitivity
(Nees & Becker, 2017; Nees et  al., 2017) and provides a potential explanation of why abnormalities in the MCC during pain perception
are present in PwPD.
Thus, the MCC and SMA are important for the processing of nociceptive information and provide a putative anatomical substrate for
enhanced top‐down modulation of incoming nociceptive information.
4.4. Laser‐evoked potential
The LEP was not significantly different between the two groups, yet did show a significant difference between low and high laser
stimuli. The subjective experience of pain was standardised in both groups, such that participants experienced what they subjectively
considered to be a low and high pain. We therefore did not expect a group difference in the LEP. The relationship between LEP and
behavioural response has been reported to be highly variable and thus is not an accurate characteristic of pain processing to draw
conclusions from (Iannetti, Hughes, Lee, & Mouraux, 2008; Mouraux & Iannetti, 2009).
Although research has previously shown that an altered degree of anticipation can modulate the LEP amplitude and pain
unpleasantness, there is research by Clark et al., 2008 which reported that the characteristics of the LEP, specifically the P2 peak, were
not affected by the duration of the anticipation period, nor correlated to the behavioural pain ratings. They concluded that the
anticipatory response is more closely aligned with attentional processing rather than intensity coding of the stimulus. These findings
are consistent with the results from this study and hence help to explain of how a difference during the anticipatory period did not
affect the LEP response.
4.5. Considerations of interpretation
The MCC and SMA are regions associated with nociceptive processing; however, their activation is not unique to nociceptive processing.
The regions are also associated with the processing of non‐nociceptive salient stimuli (Mouraux, Diukova, Lee, Wise, & Iannetti, 2011)
and highlight that the cortical activity may not be unique to nociception. Therefore, a limitation in our interpretation is that the study
did not include non‐painful control stimuli. This would have allowed us to establish whether the abnormal anticipation response in PD
patients is unique to pain anticipation. We would therefore recommend further investigation using non‐painful and non‐salient stimuli
to further understand the abnormality in the PD cortical pain processing.
The present study has used source localisation to successfully quantify the anatomical origin of the activity recorded at scalp electrodes.
These differences were not directly correlated to significant changes at scalp‐level EEG and thus need to be considered when
interpreting these results. It is known that there is no simple relationship between scalp and source activity, as a single electrode
summates the potentials generated within neural sources and is dependent on the combination of the orientation, strengths and
location of these potentials. Hence, as scalp topographies are the product of the addition of multiple brain sources, it is difficult to
interpret them directly in relation to source localisation estimates. The comparison of SD‐over‐trials between the groups did not report
any differences and indicates that group differences in data variability (e.g. due to noise) are unlikely to be a factor driving group
effects at the source level. The source localisation results in this study are supported by conclusions drawn in Forkmann et  al., 2017,
which also showed increased activity within the cingulate cortex during pain perception in PwPD. Hence, we are confident that despite
not seeing scalp‐level group differences, the significant differences reported via source localisation are valid.
4.6. Clinical impact
The current perception of pain in PwPD is often considered to be a consequence of peripheral symptoms such as rigidity and stooped
posture. However, our findings suggest the possibility that the treatment for chronic pain in PD could beneficially incorporate
alternative treatments such as mindfulness and cognitive behavioural therapy (CBT). These treatments have been shown to reduce
anticipation to noxious stimuli (Brown & Jones, 2010), improve cognitive control of pain over time and reduce the severity of chronic pain
(Kabat‐Zinn, 1982; Kabat‐Zinn, Lipworth, & Burney, 1985). Nevertheless, further investigations are essential to establish whether
cognitive therapies are a suitable treatment for pain in Parkinson's disease.
5. CONCLUSION
In conclusion, Parkinson's patients demonstrated enhanced anticipatory activity within the brain before an acute pain stimulus.
Although we cannot conclude a causal link between altered anticipation in Parkinson's and the prevalence of chronic pain in PD, we have
provided evidence for altered top‐down processing of pain in Parkinson's disease, increasing the evidence for abnormal central
processing in Parkinson's and other chronic pain conditions. Our results contribute to the building knowledge of the relationship
between chronic pain and Parkinson's disease, and inform a possible scientific rational for novel treatment strategies in Parkinson's
pain, including mindfulness, cognitive therapies and other treatments targeted at reducing top‐down processing of pain.
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